Please login to the form below

Not currently logged in


This page shows the latest liraglutide news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk’s semaglutide obesity trial hits the mark

Novo Nordisk’s semaglutide obesity trial hits the mark

1 drug Saxenda (liraglutide 3mg) as an active control. ... Two thirds (65%) of subjects on semaglutide experienced weight loss of 10% or more, compared to 10% with placebo and 34% with liraglutide.

Latest news

More from news
Approximately 15 fully matching, plus 109 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Rainmaker Healthcare Communications

Rainmaker is an independent, award-winning communications agency with offices in London and Atlanta. Our experience across pharmaceuticals, generics, OTC, medical...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...